Prevalence of childhood cancer survivors increasing
the ONA take:
According to a study published in the journal Cancer Epidemiology, Biomarkers & Prevention, researchers have found that the prevalence of childhood cancer survivors is increasing, and most of those who have survived at least 5 years beyond diagnosis may have at least one comorbidity.
Using nine U.S. Surveillance, Epidemiology, and End Results (SEER) registries and data from the Childhood Cancer Survivor Study (CCSS), researchers estimated that there are 388,501 childhood cancer survivors in the United States, an increase of nearly 60,000 from the previous 2005 National Cancer Institute estimate.
Researchers found that approximately 84% of survivors have survived 5 or more years since diagnosis. The study also showed that about 70% of childhood cancer survivors have a mild or moderate chronic condition and about 32% have a severe, disabling, or life-threatening chronic condition.
The findings suggest that more needs to be done to effectively decrease morbidity burden in childhood cancer survivors, particularly those with neurocognitive dysfunction, self-reported functional impairment, activity limitations, impaired mental health, pain, or anxiety and fear.
Prevalence of childhood cancer survivors is increasing, and those who survived at least 5 years beyond diagnosis have at least one comorbidity.
- Response to Anemia Treatment Differs in Lymphoma, Multiple Myeloma
- Fertility Preservation in Male Adolescents and Young Adults With Cancer
- Impact of Prostate Cancer Diagnosis, Treatment Choice on Quality of Life
- Social, Psychiatric Variables Reduce Cognitive Functioning, QoL in HNC
- Duloxetine May Improve AI-Associated Joint Pain in Early Stage Breast Cancer
- HPV and Cancer (Fact Sheet)
- Pain Control More Easily Achieved With Nurse-Led Education in Bone Metastases
- Acupuncture an Effective Alternative Treatment for Cancer-Related Fatigue
- Using Nutrition-Based Strategies to Manage Adverse Effects of Cancer
- Palliative Care Associated With Decreased Costs For Patients With Advanced Cancer
- Exercise May Mitigate Doxorubicin-related Cardiotoxicity
- Reduced Delayed Intensification Impacts Risk of Pediatric ALL Relapse
- Exercise May Mitigate Cardiotoxicity Associated With Doxorubicin Treatment
- Mobile Health Apps Becoming More Popular Among Patients and Clinicians
- Online Learning Modules Improve Exercise Counseling, But Not Participation
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|